weight loss medication retatrutide Who Makes Retatrutide? Company Behind the Drug Retatrutide - LeadWest Medical

Other study cohorts report 6% body weight loss after 3 months and 11% after 6 months

GLP-1-oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice

GLP-1 helps regulate blood sugar levels by stimulating the release of insulin, suppressing glucagon secretion (which raises blood sugar levels), and slowing the rate at which the stomach empties, leading to a feeling of fullness and reduced appetite

Even with medically supervised bariatric surgery, patients receive nutritional guidance, routine follow-up, and long-term support to help promote safer weight loss and overall health

Comparing Retatrutide to Other Injectables Retatrutides injection site reaction profile compares favorably to other subcutaneous medications

Diabetes Therapy , 11(4), 835846